Abstract     Description     Claims     Drawing  

WO2015053381A   [0006] 
WO2002031140A   [0053]  [0083] 
JP2009225781A   [0083] 

LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-glycan on Thr52 of Platelet Aggregation-stimulating Domain of Human Podoplanin   [0007] 
The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity   [0007] 
A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin   [0007] 
Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity   [0007] 
PNAS   [0038]  [0079] 
J. Mol. Bio.   [0038]  [0079] 
J. Mol. Biol.   [0038]  [0079] 
J. Mol. Biol.   [0038]  [0079] 
Nat. Biotechnol.   [0080] 
Jpn. J. Cancer Res.   [0080] 
J. Mol. Biol.   [0080]